Comorbidities in Patients with Psoriasis

被引:153
作者
Gottlieb, Alice B. [1 ]
Dann, Frank [2 ]
机构
[1] Tufts Med Ctr, Boston, MA 02111 USA
[2] VA Med Ctr, Long Beach, CA USA
关键词
Cardiovascular disease; Metabolic syndrome; Psoriasis; Psoriatic arthritis comorbidities; C-REACTIVE PROTEIN; CARDIOVASCULAR RISK-FACTORS; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; CLINICAL-FEATURES; VASCULAR-DISEASES; MALIGNANT-TUMORS; LIPID PROFILE;
D O I
10.1016/j.amjmed.2009.06.021
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Psoriasis is a common chronic inflammatory disease that is associated with serious comorbidities, including psoriatic arthritis, reduced quality of life, depression, malignancy, and cardiovascular comorbidities. Patients with psoriasis have been shown to have an increased incidence of metabolic syndrome and cardiovascular disease compared with the general population. The chronic inflammatory nature of psoriasis has been suggested to be a contributing and potentially independent risk factor for the development of cardiovascular comorbidities. Understanding the interrelationship between these conditions is important for the management of psoriasis and the associated comorbidities. This review will focus on the range of comorbidities associated with psoriasis, with emphasis on cardiometabolic conditions and the aim of encouraging primary care physicians to screen psoriatic patients for cardiometabolic disorders and risk factors. (C) 2009 Elsevier Inc. All rights reserved. The American Journal of Medicine (2009) 122, 1150.e1-1150.e9
引用
收藏
页码:1150.e1 / 1150.e9
页数:9
相关论文
共 50 条
  • [21] Clinical Aspects and Comorbidities of Psoriasis
    Ayala, Fabio
    Ayala, Fabrizio
    JOURNAL OF RHEUMATOLOGY, 2009, 36 : 19 - 20
  • [22] Beyond the Skin Plaques: Psoriasis and Its Cardiovascular Comorbidities
    Kakarala, Chandra L.
    Hassan, Mohammad
    Belavadi, Rishab
    Gudigopuram, Sri Vallabh Reddy
    Raguthu, Ciri C.
    Gajjela, Harini
    Kela, Iljena
    Sange, Ibrahim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [23] Comorbidities associated with psoriasis: An experience from the Middle East
    Al-Mutairi, Nawaf
    Al-Farag, Shahat
    Al-Mutairi, Ahmed
    Al-Shiltawy, Mazen
    JOURNAL OF DERMATOLOGY, 2010, 37 (02) : 146 - 155
  • [24] Comorbidities and cardiovascular risk factors in patients with psoriasis
    Ribeiro Baeta, Isabela Guimaraes
    Bittencourt, Flavia Vasques
    Gontijo, Bernardo
    Andrade Goulart, Eugenio Marcos
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2014, 89 (05) : 735 - 744
  • [25] Economic burden of comorbidities in patients with psoriasis is substantial
    Kimball, A. B.
    Guerin, A.
    Tsaneva, M.
    Yu, A. P.
    Wu, E. Q.
    Gupta, S. R.
    Bao, Y.
    Mulani, P. M.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2011, 25 (02) : 157 - 163
  • [26] The Heartbreak of Psoriasis A Review of Cardiovascular Risk in Patients With Psoriasis
    Benson, Max M.
    Frishman, William H.
    CARDIOLOGY IN REVIEW, 2015, 23 (06) : 312 - 316
  • [27] Leptin, adiponectin, visfatin and retinol-binding protein-4-mediators of comorbidities in patients with psoriasis?
    Gerdes, Sascha
    Osadtschy, Svetlana
    Rostami-Yazdi, Martin
    Buhles, Norbert
    Weichenthal, Michael
    Mrowietz, Ulrich
    EXPERIMENTAL DERMATOLOGY, 2012, 21 (01) : 43 - 47
  • [28] A Review of the Epidemiology of Cardiovascular Comorbidities in Psoriasis
    Lee S.
    Wu J.J.
    Current Dermatology Reports, 2012, 1 (1) : 14 - 22
  • [29] Psoriasis and cardiovascular comorbidities with emphasis in Asia
    Chu, T. W.
    Tsai, T. -F.
    GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA, 2012, 147 (02): : 189 - 202
  • [30] Adiponectin in psoriasis and its comorbidities: a review
    Bai Ruiyang
    Panayi, Adriana
    Wu Ruifang
    Zhang Peng
    Fu Siqi
    LIPIDS IN HEALTH AND DISEASE, 2021, 20 (01)